Technology
Health
Biotechnology

CytomX

$11.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (0.51%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CytomX and other stocks, options, ETFs, and crypto commission-free!

About CTMX

CEO
Employees
137
Headquarters
Founded
2010
Market Cap
532.41M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
434.23K
High Today
$12.20
Low Today
$11.65
Open Price
$11.80
Volume
293.31K
52 Week High
$27.20
52 Week Low
$8.94

Collections

Technology
Health
Biotechnology
Therapy
Cancer Prevention
2015 IPO
US
North America

CTMX News

BenzingaJul 10

Analyst: CytomX Therapeutics Validated By AbbVie Decision

1,660

CTMX Earnings

-$0.74
-$0.48
-$0.23
$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

More CTMX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.